The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a real-world population: a comparative observational study

by Matilde Tejlbo Frost, Espen Jimenez-Solem, Mikkel Zöllner Ankarfeldt, Martin Erik Nyeland, Anne Helms Andreasen, Tonny Studsgaard Petersen
Published 2020-12-01

The “RCT augmentation”: a novel simulation method to add patient heterogeneity into phase III trials

by Helene Karcher, Shuai Fu, Jie Meng, Mikkel Zöllner Ankarfeldt, Orestis Efthimiou, Mark Belger, Josep Maria Haro, Lucien Abenhaim, Clementine Nordon, on behalf of the GetReal Consortium Work Package 2
Published 2018-07-01

A Collaborative Medication Review Including Deprescribing for Older Patients in an Emergency Department: A Longitudinal Feasibility Study

by Morten Baltzer Houlind, Aino Leegaard Andersen, Charlotte Treldal, Lillian Mørch Jørgensen, Pia Nimann Kannegaard, Luana Sandoval Castillo, Line Due Christensen, Juliette Tavenier, Line Jee Hartmann Rasmussen, Mikkel. Zöllner Ankarfeldt, Ove Andersen, Janne Petersen
Published 2020-01-01

Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients

by Espen Jimenez-Solem, Tonny S. Petersen, Casper Hansen, Christian Hansen, Christina Lioma, Christian Igel, Wouter Boomsma, Oswin Krause, Stephan Lorenzen, Raghavendra Selvan, Janne Petersen, Martin Erik Nyeland, Mikkel Zöllner Ankarfeldt, Gert Mehl Virenfeldt, Matilde Winther-Jensen, Allan Linneberg, Mostafa Mehdipour Ghazi, Nicki Detlefsen, Andreas David Lauritzen, Abraham George Smith, Marleen de Bruijne, Bulat Ibragimov, Jens Petersen, Martin Lillholm, Jon Middleton, Stine Hasling Mogensen, Hans-Christian Thorsen-Meyer, Anders Perner, Marie Helleberg, Benjamin Skov Kaas-Hansen, Mikkel Bonde, Alexander Bonde, Akshay Pai, Mads Nielsen, Martin Sillesen
Published 2021-02-01